The Globe and Mail·53 signal
Analysts Have Conflicting Sentiments on These Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Inspire Medical Systems (INSP) and Travere Therapeutics (TVTX)This article details conflicting analyst sentiments for three healthcare companies: Jazz Pharmaceuticals (JAZZ), Inspire Medical Systems (INSP), and Travere Therapeutics (TVTX). Stifel Nicolaus analysts reiterated a Buy rating for Jazz Pharmaceuticals and Inspire Medical Systems, while maintaining a Hold rating for Travere Therapeutics. The article provides individual analyst ratings, price targets, and overall Street consensus for each company.
Original source